Tyrosyl-tRNA Synthetase 2, Mitochondrial (YARS2) (C-Term) Peptide
-
- Target See all YARS2 products
- YARS2 (Tyrosyl-tRNA Synthetase 2, Mitochondrial (YARS2))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- QPDDSVERYL KLFTFLPLPE IDHIMQLHVK EPERRGPQKR LAAEVTKLVH
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-YARS2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- YARS2 (Tyrosyl-tRNA Synthetase 2, Mitochondrial (YARS2))
- Synonyms
- 2210023C10Rik Peptide, tyrRS Peptide, CGI-04 Peptide, RGD1311696 Peptide, MLASA2 Peptide, MT-TYRRS Peptide, TYRRS Peptide, tyrosyl-tRNA synthetase 2 (mitochondrial) Peptide, tyrosyl-tRNA synthetase 2 Peptide, Yars2 Peptide, YARS2 Peptide
- Background
-
This gene encodes a mitochondrial protein that catalyzes the attachment of tyrosine to tRNA(Tyr). Mutations in this gene are associated with myopathy with lactic acidosis and sideroblastic anemia type 2 (MLASA2).
Alias Symbols: MLASA2, MT-TYRRS, TYRRS
Protein Interaction Partner: CDC20,ICT1,UBC,USP49,Ybx1
Protein Size: 477 - Molecular Weight
- 52 kDa
- Gene ID
- 51067
- NCBI Accession
- NM_001040436, NP_001035526
- UniProt
- Q9Y2Z4
-